RECKON LIMITED (RKN)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

RKN

RKN - RECKON LIMITED

FNArena Sector : Accountancy
Year End: December
GICS Industry Group : Software & Services
Debt/EBITDA: 0.35
Index:

0

LAST PRICE CHANGE +/- CHANGE % VOLUME

$0.48

11 Aug
2026

0.000

OPEN

$0.49

0.000

HIGH

$0.49

94,455

LOW

$0.48

OTHER COMPANIES IN THE SAME SECTOR
XRO .
FNARENA'S MARKET CONSENSUS FORECASTS

- No Record -

Last ex-div: 14/08 - ex-div 2.50c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2026 FactSet UK Limited. All rights reserved
Title 202020212022202320242025
EPS Basic xxxxxxxxxxxxxxx6.5
DPS All xxxxxxxxxxxxxxx2.5
Sales/Revenue xxxxxxxxxxxxxxx62.4 M
Book Value Per Share xxxxxxxxxxxxxxx22.7
Net Operating Cash Flow xxxxxxxxxxxxxxx23.8 M
Net Profit Margin xxxxxxxxxxxxxxx11.80 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202020212022202320242025
Return on Capital Employed xxxxxxxxxxxxxxx30.75 %
Return on Invested Capital xxxxxxxxxxxxxxx23.41 %
Return on Assets xxxxxxxxxxxxxxx14.35 %
Return on Equity xxxxxxxxxxxxxxx30.75 %
Return on Total Capital xxxxxxxxxxxxxxx31.14 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx20.8 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202020212022202320242025
Short-Term Debt xxxxxxxxxxxxxxx1 M
Long Term Debt xxxxxxxxxxxxxxx9 M
Total Debt xxxxxxxxxxxxxxx9 M
Goodwill - Gross xxxxxxxxxxxxxxx12 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx1 M
Price To Book Value xxxxxxxxxxxxxxx2.52

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202020212022202320242025
Capex xxxxxxxxxxxxxxx15.3 M
Capex % of Sales xxxxxxxxxxxxxxx24.43 %
Cost of Goods Sold xxxxxxxxxxxxxxx45 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx8 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx0 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.0

No. Of Recommendations

0
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Moelis

06/08/2026

1

Buy

$1.01

110.42%

Moelis maintains a Buy rating for Reckon with a $1.01 target price following first-half 2026 results highlighting key product development milestones.

Feature releases within Reckon One narrowed the functionality gap against legacy product ReckonAccounts ahead of expectations, enabling client migration towards cloud offerings.

Slower sales ramp-ups and foreign exchange movements across the Legal Group prompted a -$2.1m reduction in 2026 revenue projections, though lower operating expenses limited net profit revisions to $7m from $7.2m previously.

Addressing an estimated $2.5m annualised installation backlog in the Legal Group offers near-term revenue upside as staff turnover stabilises.

The analyst considers current trading levels deeply discounted, with valuation models reflecting low single-digit growth without pricing in development re-prioritisation opportunities.

FORECAST
Moelis forecasts a full year FY26 dividend of 2.50 cents and EPS of 6.20 cents.
Moelis forecasts a full year FY27 dividend of 2.50 cents and EPS of 6.90 cents.

RKN STOCK CHART